novo nordisk glp-1 receptor agonist weight management diabetes treatments Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Agonists | Advances in Therapy Researchers reveal benefits, risks linked

In controlled studies, glutathione supplementation increased peroxisome proliferator-activated receptor- coactivator-1 (PGC-1) protein levels by 25% and mitochondrial DNA biogenesis by 53% in skeletal muscle, indicating enhanced mitochondrial function supporting exercise capacity

72 highlighted the fact that senescent cancer cells could be used as cancer vaccine by activating the antitumor immunity

Mira Meeus, Jo Nijs, Linda Hermans, Dorien Goubert & Patrick Calders (2013) The role of mitochondrial dysfunctions due to oxidative and nitrosative stress in the chronic pain or chronic fatigue syndromes and fibromyalgia patients: peripheral and central mechanisms as therapeutic targets?, Expert Opinion on Therapeutic Targets, 17:9, 1081-1089, DOI: 10.1517/14728222.2013.818657 Myhill S, Booth NE, McLaren-Howard J

After 1 year, 55.4% of the patients (4494493 out of 1595) who received lorcaserin and 45.1% of the patients (716 out of 154497) who received the placebo remained in the trial, and 1553 patients continued into the second year

BOC Sciences employs advanced liposome formulation and homogenization technologies to tailor the physicochemical architecture of the liposome: Phase Transition Engineering: Selecting lipid blends with optimal phase transition temperatures (Tm) to construct a rigid, impermeable shell that minimizes oxygen diffusion and prevents premature leakage during storage

Neuropharmacol ., 38 (1), 1117